GT Biopharma (GTBP) EPS (Diluted) (2012 - 2026)
Powered by 
Analysis
GT Biopharma (GTBP) EPS (Diluted) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 0.66 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -0.06 |
| 10 | GT Biopharma | 337,746.23 | 337,746.23 | - | -2.78 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2.78 |
| Dec 31, 2025 | -34.08 |
| Sep 30, 2025 | 25.99 |
| Jun 30, 2025 | -272.88 |
| Mar 31, 2025 | -8.27 |
| Dec 31, 2024 | -49.74 |
| Sep 30, 2024 | -38.17 |
| Jun 30, 2024 | -54.18 |
| Mar 31, 2024 | -53.40 |
| Dec 31, 2023 | -54.68 |
| Sep 30, 2023 | -53.14 |
| Jun 30, 2023 | -67.62 |
| Mar 31, 2023 | -85.72 |
| Dec 31, 2022 | -135.98 |
| Sep 30, 2022 | -167.87 |
| Jun 30, 2022 | -72.37 |
| Mar 31, 2022 | -930.89 |
| Dec 31, 2021 | -3,112.21 |
| Sep 30, 2021 | -1,013.00 |
| Jun 30, 2021 | -831.51 |